144 related articles for article (PubMed ID: 17138119)
1. Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography.
Cavanaugh D; Travis EL; Price RE; Gladish G; White RA; Wang M; Cody DD
Acad Radiol; 2006 Dec; 13(12):1505-12. PubMed ID: 17138119
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative measurement of murine bleomycin-induced lung fibrosis in in vivo and postmortem conditions using microcomputed tomography: correlation with pathologic scores--initial results.
Lee HJ; Goo JM; Kim NR; Kim MA; Chung DH; Son KR; Kim HC; Lee CH; Park CM; Chun EJ; Im JG
Invest Radiol; 2008 Jun; 43(6):453-60. PubMed ID: 18496052
[TBL] [Abstract][Full Text] [Related]
3. Imaging techniques for small animal imaging models of pulmonary disease: micro-CT.
Johnson KA
Toxicol Pathol; 2007 Jan; 35(1):59-64. PubMed ID: 17325973
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of rosiglitazone on bleomycin-induced lung fibrosis: Assessed by micro-computed tomography and pathologic scores.
Jin GY; Bok SM; Han YM; Chung MJ; Yoon KH; Kim SR; Lee YC
Eur J Radiol; 2012 Aug; 81(8):1901-6. PubMed ID: 21296518
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model.
Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U
Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004
[TBL] [Abstract][Full Text] [Related]
6. A micro-computed tomography-based method for the measurement of pulmonary compliance in healthy and bleomycin-exposed mice.
Shofer S; Badea C; Auerbach S; Schwartz DA; Johnson GA
Exp Lung Res; 2007; 33(3-4):169-83. PubMed ID: 17558678
[TBL] [Abstract][Full Text] [Related]
7. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S
J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume.
Vande Velde G; Poelmans J; De Langhe E; Hillen A; Vanoirbeek J; Himmelreich U; Lories RJ
Dis Model Mech; 2016 Jan; 9(1):91-8. PubMed ID: 26563390
[TBL] [Abstract][Full Text] [Related]
9. Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography.
De Langhe E; Vande Velde G; Hostens J; Himmelreich U; Nemery B; Luyten FP; Vanoirbeek J; Lories RJ
PLoS One; 2012; 7(8):e43123. PubMed ID: 22912805
[TBL] [Abstract][Full Text] [Related]
10. Quantitative measurement of bleomycin-induced lung fibrosis in rabbits using sequential in vivo regional analysis and high-resolution computed tomography: correlation with pathologic findings.
Nagatani Y; Nitta N; Otani H; Mukaisho K; Sonoda A; Nitta-Seko A; Takahashi M; Murata K
Acad Radiol; 2011 Jun; 18(6):672-81. PubMed ID: 21393029
[TBL] [Abstract][Full Text] [Related]
11. Correlation between high resolution computed tomography and tissue morphometry of the lung in bleomycin-induced pulmonary fibrosis in the rabbit.
Hirose N; Lynch DA; Cherniack RM; Doherty DE
Am Rev Respir Dis; 1993 Mar; 147(3):730-8. PubMed ID: 7680190
[TBL] [Abstract][Full Text] [Related]
12. Serial micro-CT assessment of the therapeutic effects of rosiglitazone in a bleomycin-induced lung fibrosis mouse model.
Choi EJ; Jin GY; Bok SM; Han YM; Lee YS; Jung MJ; Kwon KS
Korean J Radiol; 2014; 15(4):448-55. PubMed ID: 25053904
[TBL] [Abstract][Full Text] [Related]
13. Bleomycin-induced fibrosis in pigs: evaluation with CT.
Balazs G; Noma S; Khan A; Eacobacci T; Herman PG
Radiology; 1994 Apr; 191(1):269-72. PubMed ID: 7510895
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis.
Gilhodes JC; Julé Y; Kreuz S; Stierstorfer B; Stiller D; Wollin L
PLoS One; 2017; 12(1):e0170561. PubMed ID: 28107543
[TBL] [Abstract][Full Text] [Related]
15. A micro-CT analysis of murine lung recruitment in bleomycin-induced lung injury.
Shofer S; Badea C; Qi Y; Potts E; Foster WM; Johnson GA
J Appl Physiol (1985); 2008 Aug; 105(2):669-77. PubMed ID: 18566189
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin-induced lung injury in mice investigated by MRI: model assessment for target analysis.
Babin AL; Cannet C; Gérard C; Saint-Mezard P; Page CP; Sparrer H; Matsuguchi T; Beckmann N
Magn Reson Med; 2012 Feb; 67(2):499-509. PubMed ID: 21656559
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of two mouse models of lung fibrosis induced by intratracheal instillation and intratracheal aerosol administration of bleomycin].
Li W; Hu Y; Yuan W; Li L; Huang W
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):221-5. PubMed ID: 22381763
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation.
Scotton CJ; Hayes B; Alexander R; Datta A; Forty EJ; Mercer PF; Blanchard A; Chambers RC
Eur Respir J; 2013 Dec; 42(6):1633-45. PubMed ID: 23520313
[TBL] [Abstract][Full Text] [Related]
19. Microfocal CT: a method for evaluating murine cranial sutures in situ.
Recinos RF; Hanger CC; Schaefer RB; Dawson CA; Gosain AK
J Surg Res; 2004 Feb; 116(2):322-9. PubMed ID: 15013372
[TBL] [Abstract][Full Text] [Related]
20. Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology.
Egger C; Cannet C; Gérard C; Jarman E; Jarai G; Feige A; Suply T; Micard A; Dunbar A; Tigani B; Beckmann N
PLoS One; 2013; 8(5):e63432. PubMed ID: 23667616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
